https://insights.citeline.com/medtech-insight/device-area/ophthalmology/alcon-vs-jj-rivalry-of-edof-cataract-market-heats-up-with-jjs-planned-launch-of-tecnis-puresee-WV2HKV3T65AXZML7JPF5WGMT6I/2026-04-17T22:49:51.384Zalways0.5https://insights.citeline.com/resizer/hTV6bDZDfxFcVLyA7GJzy0RmYy4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y6XC47J4JZF4LHYXWQTEQ6S3HI.jpghttps://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/recent-and-upcoming-us-fda-advisory-committee-meetings-BPOIZNTRCJF57DRQSK77MYTCPQ/2026-04-17T22:43:26.098Zalways0.5https://insights.citeline.com/resizer/zK-1qhNmlz4zZcY6O0wKSeyretY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RGEVRT2KERADXPSY5GK6MDEY7M.jpghttps://insights.citeline.com/pink-sheet/podcasts/pink-sheet-podcast-cber-director-candidate-emerges-us-fda-promotes-leucovorin-pathway-ZW5MTTYSL5GF5LJVCI7RYZBHTU/2026-04-17T22:43:09.007Zalways0.5https://insights.citeline.com/resizer/Gg_gWrVctvsFBg1CcB-LKDTCOc4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JVY5PWDGIFNT3GV6SLTK2YSK5I.pnghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/msds-oral-pcsk9-inhibitor-for-hypercholesterolemia-among-seven-new-eu-filings-PIND6CEPRZFC3JTLMELBDK5IDA/2026-04-17T22:42:50.532Zalways0.5https://insights.citeline.com/resizer/tpXnOMhllxImzr90zoaXRmUUgUQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KFMU4ZHXNVGC7KX37O3AW3J7OQ.jpghttps://insights.citeline.com/pink-sheet/legislation/eu-pharma-legislation-reform/eu-pharma-reform-the-changes-ahead-OVHXI7EOENGARNB5GCQKUAVO6M/2026-04-17T22:42:04.348Zalways0.5https://insights.citeline.com/resizer/sCZw0spLM6yHaotax8eFNz5da6w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QMBCLFFSBBFNNGJHZEPXH5DY2E.jpghttps://insights.citeline.com/pink-sheet/agency-leadership/us-fda/after-layoffs-hhs-plans-12000-new-hires-aligned-with-trump-administration-priorities-MKX6AZ5RRRA4LK2L2N3M2EGM3A/2026-04-17T22:41:45.39Zalways0.5https://insights.citeline.com/resizer/mxJCr5YcteCs2JfGEsn5srKpnFU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JNPSK36BFRDBFEIMR4RREH6REU.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/cnpv-for-life-lillys-foundayo-filing-plans-suggest-voucher-can-span-indications-3ZGTODRCZ5EFZB52CQVMNRABWU/2026-04-17T22:41:35.948Zalways0.5https://insights.citeline.com/resizer/42_GB8PaZ6q5TitZlfpKgpWPMFw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KOMKYJ7LMVCZ5GL2KQ3XDD335I.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/uk-turns-a-corner-on-clinical-trial-set-up-times-but-low-recruitment-still-a-concern-VA7SBSGEE5CDTJBNZRJXOE5OYA/2026-04-17T22:41:24.164Zalways0.5https://insights.citeline.com/resizer/55q67pfB51yXvKDMj_7h2_k6Sgo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HBKTXWM2KZAYRALFCFKQFHSUZQ.jpghttps://insights.citeline.com/hbw-insight/beauty/business/marketing-and-advertising/personal-care-brands-serve-up-spring-campaigns-with-sponsorships-partners-6CL2455A2RCS7KDWG46OEZFC44/2026-04-17T22:14:48.021Zalways0.5https://insights.citeline.com/resizer/Dd7R_62ybPqDOijIZ1i0YKTcynM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BW3JDPYO2NHSBHBZFHCISA6OD4.jpghttps://insights.citeline.com/scrip/business/legalandip/lupin-follows-sandoz-sun-in-antitrust-suit-settlement-30m-for-humana-XUQC7QPY7NCHHANDFIUT57Z6WQ/2026-04-17T21:26:11.895Zalways0.5https://insights.citeline.com/resizer/Qw8fKf3ie5S6CM-W5cqBuSrsuBk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SBMOJ7GT5NBDPKCHF3JJI2ESCI.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-oricell-terremoto-neomorph-raise-venture-mega-rounds-W43TIDO6NZHAXHOJBCU6GR2F3Y/2026-04-17T21:25:42.963Zalways0.5https://insights.citeline.com/resizer/cInTrHhf4lm96TCzMQLN0bLTTRI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SDNUC6JU3VLANCGYXXII3MD4RM.jpghttps://insights.citeline.com/scrip/advanced-therapies/gene-therapies/meiragtx-brings-rare-eye-disease-gene-therapy-back-home-5FSEXSKIGNDJ3NKWYHBNP3GUTE/2026-04-17T21:23:46.589Zalways0.5https://insights.citeline.com/resizer/l_N3I4WWePrM-fDJmkLYmiRVUtA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BL7SGYWNTJJRVM6J3WQ2LAOIY4.jpghttps://insights.citeline.com/scrip/business/deals/deal-watch/ucb-looks-to-bolster-its-epilepsy-pipeline-with-neurona-buyout-Z677AOABDJGG7IKYTKZNPNIVUE/2026-04-17T21:23:16.308Zalways0.5https://insights.citeline.com/resizer/q4wJd1ALhCJuzFBi3H_jiLlOywE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/47PO2BXDRBB7BLCCOSDLMJHQSA.jpghttps://insights.citeline.com/scrip/business/financing/kailera-ipo-is-biggest-so-far-in-2026-may-become-biopharmas-largest-in-the-us-EMY324OYS5H4TEBSZJO36RJIBI/2026-04-17T21:22:57.139Zalways0.5https://insights.citeline.com/resizer/4ltNjJ3KC3q2rkQm8Qxkhc9gaIA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MKBAILBCJ5BJFJP6XNRPZXW7ME.jpghttps://insights.citeline.com/medtech-insight/business/earnings/abbott-trims-earnings-guidance-on-exact-sciences-deal-but-maintains-sales-outlook-WBFJ76V5OVCUJHLQA5YOMMDWKA/2026-04-17T19:55:13.67Zalways0.5https://insights.citeline.com/resizer/NefXSkfr4t_qjXFhG0w2EWzXEkY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VTNZHXIHMFEBFEJDAOPH2JHIMY.jpghttps://insights.citeline.com/generics-bulletin/legalandip/hikma-hits-back-over-amarins-strawman-induced-infringement-claims-PSI5LAMDUZGFHDCTQKJY2BBAPY/2026-04-17T15:08:44.537Zalways0.5https://insights.citeline.com/resizer/bBXccB-MCD9lyYsjYPUnOzpDNAc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y7J3VBNZKZCIBNQCSW5WH3364E.jpghttps://insights.citeline.com/hbw-insight/leadership/us-consumer-health-executive-moves-crnradicle-award-designs-for-health-gimme-seaweed-more-23VWUCYMDBGTZHGA2RDC2BBS54/2026-04-17T14:54:34.985Zalways0.5https://insights.citeline.com/resizer/fNNZZuQsqn25UmkgLw0I8ovBTzc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/W7HD3ITXPFBCDGOQUZMMALAJ44.jpghttps://insights.citeline.com/in-vivo/innovation/how-an-italian-ocular-aav-innovator-is-bucking-the-trend-in-gene-therapy-63OPEMWE5ZFPFDYCTUXVGHSRMU/2026-04-17T14:46:47.435Zalways0.5https://insights.citeline.com/resizer/l_N3I4WWePrM-fDJmkLYmiRVUtA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BL7SGYWNTJJRVM6J3WQ2LAOIY4.jpghttps://insights.citeline.com/generics-bulletin/business/deals/mabwell-finds-a-denosumab-biosimilar-partner-in-malaysia-AIHCZR4ZH5H7BEIG3YVEGE2SCU/2026-04-17T14:39:48.019Zalways0.5https://insights.citeline.com/resizer/fTTlizLdNgy-Hk4TO0rD_O6nRSI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HETPJMCVFNHDFLEGA23RNT5HAY.jpghttps://insights.citeline.com/pink-sheet/legislation/why-india-is-considering-the-essential-commodities-act-for-pharma-amid-iran-war-E2K4C6TO7FEYHNUTQREDWYJSRI/2026-04-17T14:13:37.425Zalways0.5https://insights.citeline.com/resizer/TJtdgk40utzmVNfAaEEtBxxktRQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YIGANQK24FFZNK5JKFOJEH7IVM.jpghttps://insights.citeline.com/pink-sheet/market-access/prolonged-iran-ports-blockade-risks-drug-shortages-wider-supply-chain-woes-OVV2Q5N5RBFARHDE44FPU6XK5A/2026-04-17T14:10:45.588Zalways0.5https://insights.citeline.com/resizer/t2uGrXbrImnkjA2XhokAhWNJiUY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7PWBKJNARRBJJGPSUZRTV5LACQ.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-market-struggles-on-iran-war-jobs-data-impacting-biopharma-stocks-3TP24YPCHZH5JNHLEXEBVSIFYY/2026-04-17T13:08:42.597Zalways0.5https://insights.citeline.com/resizer/QP0XsTOKIkbEiMw2sxA1vTD-XIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUPCCTOSUNI7ZKUU3DO7RIZNHI.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-volatility-impacts-ipos-in-the-us-but-biopharma-is-a-standout-SG5LQH7FXVAH5LCDMQK3NYSNKY/2026-04-17T13:07:59.497Zalways0.5https://insights.citeline.com/resizer/QP0XsTOKIkbEiMw2sxA1vTD-XIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUPCCTOSUNI7ZKUU3DO7RIZNHI.jpghttps://insights.citeline.com/scrip/business/supply-chain/amid-iran-war-india-tries-to-keep-lights-on-with-duty-cuts-PMW77UO2HZH4JEFN2ADJJ4PIZU/2026-04-17T13:07:32.768Zalways0.5https://insights.citeline.com/resizer/BegAK9cO331jGHha6kUvgqh8PDg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QAVEVFLU7BH3ZGD3F42E7X3HPE.jpghttps://insights.citeline.com/scrip/business/earnings/az-optimistic-on-japan-prospects-despite-pricing-loe-challenges-DKBVZ6JYTRCDHKA2U33Y7Z7AMI/2026-04-17T13:06:38.644Zalways0.5https://insights.citeline.com/resizer/ooWRRRuAysoqCsb99POftf5loLY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MX66A5YKL5BDHLPGBXBTQC22SA.jpghttps://insights.citeline.com/scrip/business/supply-chain/prolonged-us-blockade-of-iran-ports-risks-drug-shortages-wider-supply-chain-woes-SEMZ4LNEPVA63KV7XAUFT6VCJY/2026-04-17T13:06:23.123Zalways0.5https://insights.citeline.com/resizer/_ynXHk6n6kXasqPeYEY4TEGwTDQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6B2NLA3LNBDAPKLB4OGCGYCEJI.jpghttps://insights.citeline.com/scrip/podcasts/japan-q1-roundup-podcast-iran-war-impact-divestments-product-approvals-CXMY6RK6PRCV5MZBXTBTQQ2BEE/2026-04-17T13:05:28.634Zalways0.5https://insights.citeline.com/resizer/Se-vDyQZyT8_U2adNrPJLTsD9Lc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SMDB65DUSVENPKZHFR4ADUX3TY.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/regulation/northern-ireland-devices-to-use-eudamed-in-may-K7STPOZ6M5F5NMFQPHQRHOZ6BQ/2026-04-17T13:02:40.66Zalways0.5https://insights.citeline.com/resizer/rthj1fHxxcTiSIOnnyr7kWbwNS0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/V7QXWYYNK5GI7IHEFSFJ5FXCSY.pnghttps://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/pagb-hosts-swedish-delegation-to-share-rx-to-otc-and-prevention-best-practice-37A5BG2YUVC5HOQD7K7GXYIDKU/2026-04-17T12:50:18.25Zalways0.5https://insights.citeline.com/resizer/y9Dvd26P-912gx_GQIpJyoJ3dPQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZL5HOQU55NGITCMQAIUI2SXGT4.jpghttps://insights.citeline.com/generics-bulletin/products/generics/amneal-builds-scale-in-us-drug-device-respiratory-market-VRHFGXXDONEJ7NLQJJTH3BGE5A/2026-04-17T12:48:55.072Zalways0.5https://insights.citeline.com/resizer/K67WK3Pl6qnXQqHYT71aHWpk8dw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/U4KMU7EVHRNGHLO3BRXFYYWDRM.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/former-cdrh-diagnostics-lead-deputy-fda-commissioner-tapped-for-hhs-senior-counselor-role-GNHEGKARRFGIHG4FAVPZPAWE6E/2026-04-17T12:26:55.364Zalways0.5https://insights.citeline.com/resizer/VNvqvYK1A2eUcDfaqsAeCSLQhSs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GX7HH2UZNJLHFPJS4O3MEIIZJY.jpghttps://insights.citeline.com/pink-sheet/regulatory-trackers/european-performance-tracker/eu-filings2026-04-17T11:10:14.61Zalways0.5https://insights.citeline.com/generics-bulletin/business/deals/mochida-chases-gap-in-japanese-ivf-biosimilars-ZRCQY7V7MBFXRENYEXYEGVIVE4/2026-04-17T10:45:41.548Zalways0.5https://insights.citeline.com/resizer/sxp3SdRfo5D4rFcQpKvko4asL8E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3JDSJGV2BJARXILPMB2P3K4RQE.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/freya-lines-up-fb301-phase-ii-push-after-promising-early-stage-data-2GYLRW5ONBF57FHYAXSCCHO5X4/2026-04-17T08:59:36.057Zalways0.5https://insights.citeline.com/resizer/npqTciVwzRV6IOUQXu4Cg9VW3jo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4SRSRV5MBBHQDEZ3PU33JOJPR4.jpghttps://insights.citeline.com/pink-sheet/geography/asia/japan/japan-q1-roundup-podcast-iran-war-impact-divestments-product-approvals-P2KZDZYWFVGS5GEZ3CCGRKPUNE/2026-04-17T05:13:45.282Zalways0.5https://insights.citeline.com/resizer/Gg_gWrVctvsFBg1CcB-LKDTCOc4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JVY5PWDGIFNT3GV6SLTK2YSK5I.pnghttps://insights.citeline.com/pink-sheet/market-access/government-payers/japan-pricing-roundup-rapid-idvynso-reimbursement-cea-cut-for-briviact-TDODBRQRTFACVPS42JIFWWGY3Y/2026-04-17T00:40:22.814Zalways0.5https://insights.citeline.com/resizer/ejFLYczeavA-yKSS3GyxdZH-iZI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YHQGZMONVFE37OA2UGA7X2FGL4.jpghttps://insights.citeline.com/companies/clemann-group-sas2026-04-17T00:13:38.446Zalways0.5https://insights.citeline.com/companies/immupharma-biotech-sas2026-04-17T00:13:36.645Zalways0.5https://insights.citeline.com/companies/cunde-medical-technology-co-ltd2026-04-17T00:13:32.625Zalways0.5https://insights.citeline.com/companies/moogene-medi-co-ltd2026-04-17T00:13:28.477Zalways0.5https://insights.citeline.com/companies/chempartner-pharmatech-co-ltd2026-04-17T00:13:24.401Zalways0.5https://insights.citeline.com/companies/beijing-houmzen-pharmaceutical-technology-co-ltd2026-04-17T00:13:20.498Zalways0.5https://insights.citeline.com/companies/neurofit2026-04-17T00:13:14.568Zalways0.5https://insights.citeline.com/companies/robotimize-pte-ltd2026-04-17T00:13:10.097Zalways0.5https://insights.citeline.com/companies/shanghai-celliver-biotechnology-co-ltd2026-04-17T00:13:06.118Zalways0.5https://insights.citeline.com/companies/kupando-gmbh2026-04-17T00:13:02.223Zalways0.5https://insights.citeline.com/companies/endolipid-therapeutics2026-04-17T00:13:00.262Zalways0.5https://insights.citeline.com/companies/pharmgen-science-inc2026-04-17T00:12:56.161Zalways0.5https://insights.citeline.com/companies/anxo-pharmaceutical-co-ltd2026-04-17T00:12:51.992Zalways0.5https://insights.citeline.com/companies/university-of-exeter2026-04-17T00:12:47.981Zalways0.5https://insights.citeline.com/companies/artivila-therapeutics2026-04-17T00:12:44.025Zalways0.5https://insights.citeline.com/companies/pinnacle-medicines2026-04-17T00:12:40.14Zalways0.5https://insights.citeline.com/companies/eos-senolytix-inc2026-04-17T00:12:36.045Zalways0.5https://insights.citeline.com/companies/biozen-limited2026-04-17T00:12:31.897Zalways0.5https://insights.citeline.com/companies/spliceor-therapeutics2026-04-17T00:12:28.238Zalways0.5https://insights.citeline.com/companies/es-therapeutics-australia2026-04-17T00:12:24.029Zalways0.5https://insights.citeline.com/companies/shijiazhuang-no4-pharmaceutical-co2026-04-17T00:12:19.83Zalways0.5https://insights.citeline.com/companies/neurothera-labs-inc2026-04-17T00:12:11.661Zalways0.5https://insights.citeline.com/companies/curatis-ag2026-04-17T00:12:04.013Zalways0.5https://insights.citeline.com/companies/sichuan-yanyang-biotechnology-co-ltd2026-04-17T00:11:59.858Zalways0.5https://insights.citeline.com/companies/parr-bio2026-04-17T00:11:53.759Zalways0.5https://insights.citeline.com/companies/sumitomo-bakelite-group2026-04-17T00:11:49.843Zalways0.5https://insights.citeline.com/companies/renascience-inc2026-04-17T00:11:47.656Zalways0.5https://insights.citeline.com/companies/genemagic-biosciences2026-04-17T00:11:40.116Zalways0.5https://insights.citeline.com/companies/ouro-medicines2026-04-17T00:11:35.556Zalways0.5https://insights.citeline.com/companies/fluid-biomed2026-04-17T00:11:31.553Zalways0.5https://insights.citeline.com/companies/fastwave-medical-inc2026-04-17T00:11:27.571Zalways0.5https://insights.citeline.com/companies/fivephusion2026-04-17T00:11:23.65Zalways0.5https://insights.citeline.com/companies/shanghai-reinovax-biologics-co-ltd2026-04-17T00:11:19.659Zalways0.5https://insights.citeline.com/companies/theialife2026-04-17T00:11:07.443Zalways0.5https://insights.citeline.com/companies/smsbiotech2026-04-17T00:11:05.342Zalways0.5https://insights.citeline.com/companies/glucomodicum2026-04-17T00:11:03.396Zalways0.5https://insights.citeline.com/companies/glioblastoma-foundation-inc2026-04-17T00:11:01.376Zalways0.5https://insights.citeline.com/companies/synnovation-therapeutics2026-04-17T00:10:59.284Zalways0.5https://insights.citeline.com/companies/superluminal-medicines-inc2026-04-17T00:10:57.133Zalways0.5https://insights.citeline.com/companies/imbioray-hangzhou-biomedicine-co-ltd2026-04-17T00:10:53.266Zalways0.5https://insights.citeline.com/companies/piramal-pharma-ltd2026-04-17T00:10:49.146Zalways0.5https://insights.citeline.com/companies/diamante-srl2026-04-17T00:10:45.026Zalways0.5https://insights.citeline.com/companies/grunenthal-meds2026-04-17T00:10:41.157Zalways0.5https://insights.citeline.com/companies/valentech-pharma-colombia-sas2026-04-17T00:10:36.974Zalways0.5https://insights.citeline.com/companies/sk-bioscience-co-ltd2026-04-17T00:10:28.986Zalways0.5https://insights.citeline.com/companies/ningbo-krka-menovo-pharmaceutical-co-ltd2026-04-17T00:10:25.048Zalways0.5https://insights.citeline.com/companies/turn-biotechnologies-inc2026-04-17T00:10:20.929Zalways0.5https://insights.citeline.com/companies/essential-pharma2026-04-17T00:10:16.781Zalways0.5https://insights.citeline.com/companies/aardvark-therapeutics-inc2026-04-17T00:10:12.902Zalways0.5https://insights.citeline.com/companies/protagenic-therapeutics-inc2026-04-17T00:10:08.862Zalways0.5https://insights.citeline.com/companies/i2o-therapeutics-inc2026-04-17T00:10:05.032Zalways0.5https://insights.citeline.com/companies/shasqi-inc2026-04-17T00:10:00.656Zalways0.5https://insights.citeline.com/companies/shanghai-zj-bio-tech-co-ltd2026-04-17T00:09:56.63Zalways0.5https://insights.citeline.com/companies/stcube-inc2026-04-17T00:09:52.654Zalways0.5https://insights.citeline.com/companies/reig-jofre2026-04-17T00:09:44.573Zalways0.5https://insights.citeline.com/companies/chengdu-sino-strong-pharmaceutical-co-ltd2026-04-17T00:09:40.522Zalways0.5https://insights.citeline.com/companies/beijing-strong-biotechnologies-inc2026-04-17T00:09:29.495Zalways0.5https://insights.citeline.com/companies/twi-biotechnology-inc2026-04-17T00:09:23.551Zalways0.5https://insights.citeline.com/companies/xiamen-tebao-biotechnology-co-ltd2026-04-17T00:09:17.565Zalways0.5https://insights.citeline.com/companies/tabuk-pharmaceutical-manufacturing-co2026-04-17T00:09:05.553Zalways0.5https://insights.citeline.com/companies/natco-pharma-limited2026-04-17T00:09:02.455Zalways0.5https://insights.citeline.com/companies/shanghai-affinity-biopharmaceutical-co-ltd2026-04-17T00:08:59.209Zalways0.5https://insights.citeline.com/companies/nikon-corporation2026-04-17T00:08:53.263Zalways0.5https://insights.citeline.com/companies/university-of-otago2026-04-17T00:08:47.295Zalways0.5https://insights.citeline.com/companies/mcgill-university2026-04-17T00:08:41.183Zalways0.5https://insights.citeline.com/companies/university-of-leicester2026-04-17T00:08:35.363Zalways0.5https://insights.citeline.com/companies/queens-university2026-04-17T00:08:29.155Zalways0.5https://insights.citeline.com/companies/university-of-miami2026-04-17T00:08:23.541Zalways0.5https://insights.citeline.com/companies/redwood-pharma-ab2026-04-17T00:08:17.133Zalways0.5https://insights.citeline.com/companies/acepodia-inc2026-04-17T00:08:11.163Zalways0.5https://insights.citeline.com/companies/kowa-pharmaceuticals-america-inc2026-04-17T00:08:05.133Zalways0.5https://insights.citeline.com/companies/akrikhin2026-04-17T00:07:59.008Zalways0.5https://insights.citeline.com/companies/generation-bio-co2026-04-17T00:07:52.952Zalways0.5https://insights.citeline.com/companies/adagene-inc2026-04-17T00:07:46.987Zalways0.5https://insights.citeline.com/companies/auransa-inc2026-04-17T00:07:22.75Zalways0.5https://insights.citeline.com/companies/equillium-inc2026-04-17T00:07:16.808Zalways0.5https://insights.citeline.com/companies/episurf-medical-ab2026-04-17T00:07:10.734Zalways0.5https://insights.citeline.com/companies/concarlo-holdings-llc2026-04-17T00:07:04.89Zalways0.5https://insights.citeline.com/companies/applied-therapeutics-inc2026-04-17T00:06:58.641Zalways0.5https://insights.citeline.com/companies/context-therapeutics-inc2026-04-17T00:06:52.9Zalways0.5https://insights.citeline.com/companies/hightide-therapeutics-inc2026-04-17T00:06:46.637Zalways0.5https://insights.citeline.com/companies/biomx-inc2026-04-17T00:06:40.772Zalways0.5https://insights.citeline.com/companies/avanos-medical-inc2026-04-17T00:06:34.672Zalways0.5https://insights.citeline.com/companies/encellin-inc2026-04-17T00:06:28.389Zalways0.5https://insights.citeline.com/companies/glucotrack-inc2026-04-17T00:06:22.541Zalways0.5https://insights.citeline.com/companies/gan-lee-pharmaceuticals2026-04-17T00:06:16.545Zalways0.5https://insights.citeline.com/companies/simon-fraser-university2026-04-17T00:06:10.402Zalways0.5https://insights.citeline.com/companies/alx-oncology-inc2026-04-17T00:06:04.802Zalways0.5https://insights.citeline.com/companies/cleveland-clinic2026-04-17T00:05:46.446Zalways0.5https://insights.citeline.com/companies/seres-therapeutics-inc2026-04-17T00:05:40.227Zalways0.5https://insights.citeline.com/companies/hemogenyx-pharmaceuticals-plc2026-04-17T00:05:28.394Zalways0.5https://insights.citeline.com/companies/shanghai-pharmaceutical-group-co-ltd2026-04-17T00:05:22.221Zalways0.5https://insights.citeline.com/companies/inhibrx-inc2026-04-17T00:05:16.257Zalways0.5https://insights.citeline.com/companies/heartflow-inc2026-04-17T00:05:10.236Zalways0.5https://insights.citeline.com/companies/chiesi-farmaceutici-spa2026-04-17T00:05:01.158Zalways0.5https://insights.citeline.com/companies/ose-immunotherapeutics2026-04-17T00:04:49.269Zalways0.5https://insights.citeline.com/companies/alaunos-therapeutics-inc2026-04-17T00:04:37.349Zalways0.5https://insights.citeline.com/companies/abeona-therapeutics-inc2026-04-17T00:04:25.155Zalways0.5https://insights.citeline.com/companies/akari-therapeutics-plc2026-04-17T00:04:00.862Zalways0.5https://insights.citeline.com/companies/anteris-technologies-global-corp2026-04-17T00:03:48.869Zalways0.5https://insights.citeline.com/companies/oragenics-inc2026-04-17T00:03:36.881Zalways0.5https://insights.citeline.com/companies/adimmune-corporation2026-04-17T00:03:24.629Zalways0.5https://insights.citeline.com/companies/domain-therapeutics-sa2026-04-17T00:03:15.395Zalways0.5https://insights.citeline.com/companies/quantum-genomics-corp2026-04-17T00:03:00.687Zalways0.5https://insights.citeline.com/companies/avalo-therapeutics-inc2026-04-17T00:02:48.582Zalways0.5https://insights.citeline.com/companies/ab-science-sa2026-04-17T00:02:36.702Zalways0.5https://insights.citeline.com/companies/theriva-biologics-inc2026-04-17T00:02:24.549Zalways0.5https://insights.citeline.com/companies/teleflex-incorporated2026-04-17T00:02:00.461Zalways0.5https://insights.citeline.com/companies/astellas-pharma-inc2026-04-17T00:01:48.687Zalways0.5https://insights.citeline.com/companies/gilead-sciences-inc2026-04-17T00:01:36.677Zalways0.5